

Doschemen Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.60 M
- Company Age 10 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -7.28%
- Profit Growth 52.21%
- Ebitda 102.49%
- Net Worth -22.64%
- Total Assets 5.51%
About Doschemen Pharmaceuticals
Doschemen Pharmaceuticals Private Limited (DPPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 September 2014 and has a history of Ten years and six months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.60 M, as per Ministry of Corporate Affairs (MCA) records.
Devender Singh and Tarvindar Kaur serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999DL2014PTC271224
- Company No.
271224
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Sep 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Doschemen Pharmaceuticals Private Limited offer?
Doschemen Pharmaceuticals Private Limited offers a wide range of products and services, including Antibacterial Drugs, Antibiotic Medicine.
Who are the key members and board of directors at Doschemen Pharmaceuticals?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Devender Singh ![]() | Director | 03-Sep-2014 | Current |
Tarvindar Kaur ![]() | Director | 03-Sep-2014 | Current |
Financial Performance of Doschemen Pharmaceuticals.
Doschemen Pharmaceuticals Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 7.28% decrease. The company also saw a substantial improvement in profitability, with a 52.21% increase in profit. The company's net worth observed a substantial decline by a decrease of 22.64%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Doschemen Pharmaceuticals?
In 2022, Doschemen Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Surendra Consultancy Services Private Limited
Devender Singh and Tarvindar Kaur are mutual person
Charges (Loans)

There are no open charges registered against the company as per our records.
How Many Employees Work at Doschemen Pharmaceuticals?
Unlock and access historical data on people associated with Doschemen Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Doschemen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Doschemen Pharmaceuticals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Doschemen Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Doschemen Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Doschemen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
- Director Appointment
Devender Pal Singh was appointed as a Director was appointed as a Director on 03 Sep 2014 & has been associated with this company since 10 years 6 months .
- Director Appointment
Tarvindar Kaur was appointed as a Director was appointed as a Director on 03 Sep 2014 & has been associated with this company since 10 years 6 months .
- Company Incorporation
Doschemen Pharmaceuticals Private Limited was registered on 03 Sep 2014 with Roc Delhi & aged 10 years 6 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Doschemen Pharmaceuticals Private Limited?
Doschemen Pharmaceuticals Private Limited was incorporated on 03 Sep 2014.
What is authorized share capital and paid-up capital of Doschemen Pharmaceuticals Private Limited?
The authorized share capital of Doschemen Pharmaceuticals Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.60 M.
Who are the current board members & directors of Doschemen Pharmaceuticals Private Limited?
Currently 2 directors are associated with Doschemen Pharmaceuticals Private Limited.
- Devender Pal Singh
- Tarvindar Kaur
What is the registered address of Doschemen Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Doschemen Pharmaceuticals Private Limited is Office No. 113 114 First Floor Plot 3 Jaina Tower District Center, Janakpuri India, New Delhi, 110058.
What is the corporate identification number (CIN) and company number of Doschemen Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Doschemen Pharmaceuticals Private Limited is U74999DL2014PTC271224 and the company number is 271224 as per Ministry of Corporate Affairs (MCA).
What is the official website of Doschemen Pharmaceuticals Private Limited?
The Official website of Doschemen Pharmaceuticals Private Limited is https://www.doschemen.com
What has been the recent revenue trend for Doschemen Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Doschemen Pharmaceuticals Private Limited has fallen by -7.28%.
What change has been observed in the net worth of Doschemen Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Doschemen Pharmaceuticals Private Limited has experienced an downturn of -22.64%.
When was the last Balance Sheet of Doschemen Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Doschemen Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
People also Viewed
RO
Ravi OberoiAdditional Director